SHARE CAPITAL | 16. SHARE CAPITAL The Company’s authorized share capital consists of an unlimited number of common shares. SCHEDULE OF AUTHORIZED SHARE CAPITAL Number of shares (000’s) $ Year ended December 31, 2019 Opening balance 19,841 106,786 Shares issued on exercise of stock options 10 38 Shares issued on exercise of RSUs and DSUs 40 245 Shares issued on exercise of warrants 370 699 Shares issued from bought deal (6) 2,185 6,903 Value of shares issued in asset acquisition (4) 45 169 Balance at December 31, 2019 22,491 114,840 Year ended December 31, 2020 Opening balance 22,491 114,840 Shares issued on exercise of stock options 261 602 Shares issued on exercise of RSUs and DSUs 382 1,627 Shares issued on exercise of warrants 2 8 Shares issued on acquisition of Otis Gold Corp (1) 8,131 16,370 Shares issued as part of Credit Facility (2) 107 180 Shares issued to settle payables (3) 671 1,738 Value of shares issued in asset acquisition (4) 66 246 Shares issued to settle interest on convertible debentures (5) 228 588 Balance at December 31, 2020 32,339 136,199 Year ended December 31, 2021 Opening balance 32,339 136,199 Shares issued on exercise of stock options 15 54 Shares issued on exercise of RSUs and DSUs 281 970 Value of shares issued in asset acquisition (4) 232 305 Shares issued to settle interest on convertible debentures (5) 896 1,433 Balance at December 31, 2021 33,763 138,961 (1) On April 22, 2020, the Company completed the acquisition of Otis. Otis shareholders received 0.046 8,130,630 2.85 Excellon Resources Inc. Notes to the Consolidated Financial Statements For the years ended December 31, 2021, 2020 and 2019 (in thousands of U.S. dollars, except share and per share data) (2) On March 16, 2020, the Company closed a $ 6,000 10% September 14, 2020 107,291 (3) During the second and third quarters of 2020, the Company issued 670,974 2,098 196 261 (4) On September 24, 2019, the Company announced the Globex Agreement. The first issuance of 45,367 225 or $169 100 65,657 common shares (valued at C$ 325 or $ 246 ) on September 21, 2020 and 232,240 common shares (valued at C$ 385 or $ 305 ) on September 22, 2021 (Note 11). (5) The Company elected to pay the December 31, 2020, June 30, 2021 and December 31, 2021 interest payments on the Debentures (Note 15) in common shares valued at C$ 754 588 888 727 903 706 (6) On August 27, 2019 the Company completed a public equity financing (the “2019 Bought Deal”) of 2,185,000 5.30 11,581 Each 2019 Public Unit comprised one common share and one half-warrant (“$ 7.00 7.00 two years 1,092,500 7.00 800 The net proceeds of C$ 10,510 8,000 7.00 The outstanding number and weighted average exercise prices of equity-settled Stock Options, Purchase Warrants, Deferred Share Units (“DSUs”) and Restricted Share Units (“RSUs”) are as follows: SCHEDULE OF OUTSTANDING NUMBER AND WEIGHTED AVERAGE EXERCISE PRICES Options Warrants Options Outstanding Weighted Average Exercise Price (CAD) Warrants Outstanding (2) Weighted Average Exercise Price (CAD) RSUs Outstanding DSUs Outstanding Outstanding at January 1, 2019 260,000 6.34 370,209 2.50 352,571 372,499 Granted/issued 241,000 4.68 1,092,500 7.00 369,795 95,073 Exercised/settled (10,000 ) 2.85 (370,209 ) 2.50 (39,833 ) - Expired (20,000 ) 5.78 - - - - Forfeited (10,000 ) 4.75 - - (110,047 ) - Outstanding at December 31, 2019 461,000 5.59 1,092,500 7.00 572,485 467,572 Exercisable at December 31, 2019 270,665 5.91 1,092,500 7.00 - - Outstanding at January 1, 2020 461,000 5.59 1,092,500 7.00 572,485 467,572 Granted/issued/acquired (1) 1,002,395 3.34 1,448,488 5.23 337,331 217,264 Exercised/settled (260,596 ) 1.93 (2,400 ) 3.45 (224,750 ) (193,506 ) Expired (332,359 ) 5.20 - - (91,332 ) - Forfeited (23,003 ) 4.26 - - (128,223 ) - Outstanding at December 31, 2020 847,437 4.21 2,538,588 6.00 465,511 491,330 Exercisable at December 31, 2020 548,009 4.52 2,538,588 6.00 - 98,417 Outstanding at January 1, 2021 847,437 4.21 2,538,588 6.00 465,511 491,330 Granted/issued 257,500 3.73 - - 466,122 209,353 Exercised/settled (15,000 ) 3.05 - - (41,117 ) (244,485 ) Expired (104,366 ) 5.61 (1,092,400 ) 7.00 (54,448 ) - Forfeited (40,084 ) 3.85 - - (168,659 ) - Outstanding at December 31, 2021 945,487 3.96 1,446,188 5.24 667,409 456,198 Exercisable at December 31, 2021 816,987 4.03 1,446,188 5.24 - - (1) On April 22, 2020, the Company issued 531,895 305,060 3.30 130,365 July 22, 2020 (2) The Company has the following warrants outstanding at December 31, 2021: ● 302,760 3.30 March 29, 2022 ● 1,143,428 5.75 July 30, 2023 On August 27, 2021, 1,092,400 7.00 Excellon Resources Inc. Notes to the Consolidated Financial Statements For the years ended December 31, 2021, 2020 and 2019 (in thousands of U.S. dollars, except share and per share data) Options outstanding and exercisable as at December 31, 2021 are as follows: SCHEDULE OF OPTIONS OUTSTANDING AND EXERCISABLE Exercise Price Range (CAD) Stock Options Outstanding Weighted Average Remaining Contractual Life (years) Stock Options Exercisable Weighted Average $ 0.00 1.99 45,000 2.80 11,250 1.80 $ 2.00 3.99 423,037 1.64 411,787 3.02 $ 4.00 5.99 414,450 2.36 330,950 4.53 $ 6.00 7.99 5,000 1.30 5,000 7.50 $ 8.00 9.99 58,000 0.63 58,000 8.49 945,487 1.95 816,987 4.03 Options outstanding and exercisable as at December 31, 2020 were as follows: Exercise Price Range (CAD) Stock Options Outstanding Weighted Average Remaining Contractual Life (years) Stock Options Exercisable Weighted Average $ 2.00 3.99 502,487 2.42 294,235 3.07 $ 4.00 5.99 243,950 3.19 152,774 4.75 $ 6.00 7.99 15,000 1.40 15,000 7.63 $ 8.00 9.99 86,000 1.59 86,000 8.53 847,437 2.54 548,009 4.52 Options outstanding and exercisable as at December 31, 2019 were as follows: Exercise Price Range (CAD) Stock Options Outstanding Weighted Average Remaining Contractual Life (years) Stock Options Exercisable Weighted Average $ 0.00 2.49 24,000 0.84 24,000 1.55 $ 2.50 4.99 247,000 3.40 110,999 3.85 $ 5.00 7.49 - - - - $ 7.50 9.99 155,000 2.47 135,666 8.35 426,000 2.92 270,665 5.90 The grant date fair values of the Options were measured based on the Black-Scholes formula. Expected volatility is estimated by considering historic average share price volatility. The inputs used in the measurement of the Option fair values at grant date were the following: SCHEDULE OF MEASUREMENT OF THE OPTION FAIR VALUES AT GRANT DATE 2021 2020 2019 Fair value at grant date (CAD) $ 2.03 $ 1.64 $ 2.90 Share price at grant date (CAD) $ 3.73 $ 3.34 $ 4.65 Exercise price (CAD) $ 3.73 $ 3.34 $ 4.65 Risk free interest rate 0.39 % 0.56 % 1.71 % Expected life of options in years 3.26 5.00 5.00 Expected volatility 80.37 % 74.81 % 77.63 % Expected dividend yield 0.00 % 0.00 % 0.00 % Estimated forfeiture rate 5.87 % 4.76 % 5.40 % Compensation expense is recognized over the vesting period of the grant with the corresponding equity impact recorded in contributed surplus. Share-based compensation expense comprises the following: SCHEDULE OF SHARE BASED COMPENSATION EXPENSE 2021 2020 2019 $ $ $ Stock options 475 469 421 RSU 454 788 344 DSU 613 618 337 1,542 1,875 1,102 |